We value your privacy
We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.
Part of NATIONAL HEALTH SERVICE
Clinical Trials
2
2 active
Approvals
0
Total approvals
Agencies
Regulatory bodies
Founded
N/A
Active, not recruiting
100.0%
No approval data available
- The NHS is trialling a 15-minute blood test called MeMed BV that can rapidly distinguish between bacterial and viral infections in children, potentially saving lives by enabling faster treatment decisions for conditions like sepsis and meningitis. - The test is being evaluated at three major children's hospitals and has already demonstrated clinical benefits, with cases showing accelerated treatment for meningococcal meningitis and sepsis patients receiving immediate antibiotic therapy. - Experts estimate the technology could save dozens of young lives annually, as approximately 500 children die each year from infections with suboptimal care occurring in 40% of cases. - The rapid diagnostic tool aims to reduce unnecessary antibiotic use while ensuring critically ill children receive immediate treatment, addressing both antimicrobial resistance concerns and clinical outcomes.
